<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>13</volume><submitter>Strikic A</submitter><pubmed_abstract>Renal cell carcinoma (RCC) represents around 3% of all cancers, with the most frequent histological types being clear-cell RCC (ccRCC), followed by papillary (pRCC) and chromophobe (chRCC). Hypoxia-inducible factors (HIFs), which promote the expression of various target genes, including vascular endothelial growth factor (VEGF) and the high- affinity glucose transporter 1, have an important role in the pathogenesis of RCC. This study investigated the immunohistochemical expression of HIF-1α and VEGF-A, showing significantly higher HIF-1α nuclear expression in pRCC compared to ccRCC, while there was no significant difference in VEGF-A protein expression between the analyzed histological RCC subtypes. The quantitative reverse transcription polymerase chain reaction for &lt;i>HIF1A&lt;/i> showed no statistical difference between histological types. Data from publicly available RNA sequencing databases were analyzed and showed that, compared to healthy kidney tissue, &lt;i>VEGFA&lt;/i> was significantly up-regulated in ccRCC and significantly down-regulated in pRCC. The comparison between histological subtypes of RCC revealed that &lt;i>VEGFA&lt;/i> was significantly up-regulated in ccRCC compared to both pRCC and chRCC. There was no statistically significant difference in survival time between &lt;i>HIF1A&lt;/i> high- and low-expression groups of patients. As for &lt;i>VEGFA&lt;/i> expression, pRCC patients with low expression had a significantly higher survival rate compared to patients with high &lt;i>VEGFA&lt;/i> expression.</pubmed_abstract><journal>Frontiers in oncology</journal><pagination>1287239</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10694430</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Differential expression of &lt;i>HIF1A&lt;/i> and its downstream target &lt;i>VEGFA&lt;/i> in the main subtypes of renal cell carcinoma and their impact on patient survival.</pubmed_title><pmcid>PMC10694430</pmcid><pubmed_authors>Kelam N</pubmed_authors><pubmed_authors>Tomas SZ</pubmed_authors><pubmed_authors>Dolonga P</pubmed_authors><pubmed_authors>Kokeza J</pubmed_authors><pubmed_authors>Vukoja M</pubmed_authors><pubmed_authors>Ogorevc M</pubmed_authors><pubmed_authors>Strikic A</pubmed_authors></additional><is_claimable>false</is_claimable><name>Differential expression of &lt;i>HIF1A&lt;/i> and its downstream target &lt;i>VEGFA&lt;/i> in the main subtypes of renal cell carcinoma and their impact on patient survival.</name><description>Renal cell carcinoma (RCC) represents around 3% of all cancers, with the most frequent histological types being clear-cell RCC (ccRCC), followed by papillary (pRCC) and chromophobe (chRCC). Hypoxia-inducible factors (HIFs), which promote the expression of various target genes, including vascular endothelial growth factor (VEGF) and the high- affinity glucose transporter 1, have an important role in the pathogenesis of RCC. This study investigated the immunohistochemical expression of HIF-1α and VEGF-A, showing significantly higher HIF-1α nuclear expression in pRCC compared to ccRCC, while there was no significant difference in VEGF-A protein expression between the analyzed histological RCC subtypes. The quantitative reverse transcription polymerase chain reaction for &lt;i>HIF1A&lt;/i> showed no statistical difference between histological types. Data from publicly available RNA sequencing databases were analyzed and showed that, compared to healthy kidney tissue, &lt;i>VEGFA&lt;/i> was significantly up-regulated in ccRCC and significantly down-regulated in pRCC. The comparison between histological subtypes of RCC revealed that &lt;i>VEGFA&lt;/i> was significantly up-regulated in ccRCC compared to both pRCC and chRCC. There was no statistically significant difference in survival time between &lt;i>HIF1A&lt;/i> high- and low-expression groups of patients. As for &lt;i>VEGFA&lt;/i> expression, pRCC patients with low expression had a significantly higher survival rate compared to patients with high &lt;i>VEGFA&lt;/i> expression.</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023</publication><modification>2025-05-18T11:51:33.96Z</modification><creation>2025-05-18T11:51:33.96Z</creation></dates><accession>S-EPMC10694430</accession><cross_references><pubmed>38053655</pubmed><doi>10.3389/fonc.2023.1287239</doi></cross_references></HashMap>